<?xml version='1.0' encoding='utf-8'?>
<document id="30112986"><sentence text="Preclinical Pharmacokinetics of Triptolide: A Potential Antitumor Drug."><entity charOffset="32-42" id="DDI-PubMed.30112986.s1.e0" text="Triptolide" /></sentence><sentence text="Triptolide, a bioactive component in Tripterygium wilfordii extracts, possess strong antiproliferative activity on all 60-National Cancer Institute (NCI) cancer cell lines"><entity charOffset="0-10" id="DDI-PubMed.30112986.s2.e0" text="Triptolide" /></sentence><sentence text=" However, the widespread use of triptolide in the clinical practice is greatly limited for its multi-organ toxicity and narrow therapeutic window"><entity charOffset="32-42" id="DDI-PubMed.30112986.s3.e0" text="triptolide" /></sentence><sentence text=" All the toxic characteristics of triptolide are associated with the pharmacokinetics especially its distribution and accumulation in the target organ"><entity charOffset="34-44" id="DDI-PubMed.30112986.s4.e0" text="triptolide" /></sentence><sentence text="" /><sentence text="The literature review was done using PubMed search, SciFinder and Google Scholar databases with specific keywords such as triptolide, pharmacokinetics, drug-drug interaction, transporters, metabolism, modification to collect the related full-length articles and abstracts from 2000 to 2018"><entity charOffset="122-132" id="DDI-PubMed.30112986.s6.e0" text="triptolide" /></sentence><sentence text="" /><sentence text="Oral triptolide is rapidly and highly absorbed"><entity charOffset="5-15" id="DDI-PubMed.30112986.s8.e0" text="triptolide" /></sentence><sentence text=" Grapefruit juice affects oral absorption, increasing the area under the concentration-time curve (AUC) by 153 % and the maximum concentration (Cmax) by 141 %" /><sentence text=" The AUC and the Cmax are not dose proportional" /><sentence text=" Triptolide distributes into the liver, heart, spleen, lung and kidney"><entity charOffset="1-11" id="DDI-PubMed.30112986.s11.e0" text="Triptolide" /></sentence><sentence text=" Biotransformation of triptolide in rats includes hydroxylation, sulfate, glucuronide, N-acetylcysteine (NAC) and Glutathione (GSH) conjugation and combinations of these pathways"><entity charOffset="22-32" id="DDI-PubMed.30112986.s12.e0" text="triptolide" /><entity charOffset="65-72" id="DDI-PubMed.30112986.s12.e1" text="sulfate" /><entity charOffset="74-85" id="DDI-PubMed.30112986.s12.e2" text="glucuronide" /><entity charOffset="87-103" id="DDI-PubMed.30112986.s12.e3" text="N-acetylcysteine" /><entity charOffset="105-108" id="DDI-PubMed.30112986.s12.e4" text="NAC" /><entity charOffset="114-125" id="DDI-PubMed.30112986.s12.e5" text="Glutathione" /><entity charOffset="127-130" id="DDI-PubMed.30112986.s12.e6" text="GSH" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e0" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e1" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e3" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e4" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e5" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e0" e2="DDI-PubMed.30112986.s12.e6" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e1" e2="DDI-PubMed.30112986.s12.e1" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e1" e2="DDI-PubMed.30112986.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e1" e2="DDI-PubMed.30112986.s12.e3" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e1" e2="DDI-PubMed.30112986.s12.e4" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e1" e2="DDI-PubMed.30112986.s12.e5" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e1" e2="DDI-PubMed.30112986.s12.e6" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e2" e2="DDI-PubMed.30112986.s12.e2" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e2" e2="DDI-PubMed.30112986.s12.e3" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e2" e2="DDI-PubMed.30112986.s12.e4" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e2" e2="DDI-PubMed.30112986.s12.e5" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e2" e2="DDI-PubMed.30112986.s12.e6" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e3" e2="DDI-PubMed.30112986.s12.e3" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e3" e2="DDI-PubMed.30112986.s12.e4" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e3" e2="DDI-PubMed.30112986.s12.e5" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e3" e2="DDI-PubMed.30112986.s12.e6" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e4" e2="DDI-PubMed.30112986.s12.e4" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e4" e2="DDI-PubMed.30112986.s12.e5" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e4" e2="DDI-PubMed.30112986.s12.e6" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e5" e2="DDI-PubMed.30112986.s12.e5" /><pair ddi="false" e1="DDI-PubMed.30112986.s12.e5" e2="DDI-PubMed.30112986.s12.e6" /></sentence><sentence text=" Less than 4 % of triptolide was recovered from the feces, bile and urine within 24 h"><entity charOffset="18-28" id="DDI-PubMed.30112986.s13.e0" text="triptolide" /></sentence><sentence text=" After repeating dosage, triptolide was eliminated quickly without accumulation in vivo"><entity charOffset="25-35" id="DDI-PubMed.30112986.s14.e0" text="triptolide" /></sentence><sentence text=" As a substrate of P-glycoprotein (P-gp) and CYP3A4, triptolide could have clinically significant pharmacokinetic interactions with those proteins substrates/inhibitors"><entity charOffset="53-63" id="DDI-PubMed.30112986.s15.e0" text="triptolide" /></sentence><sentence text="" /><sentence text="The findings of this review confirm the importance of pharmacokinetic character for understanding the pharmacology and toxicology of triptolide"><entity charOffset="133-143" id="DDI-PubMed.30112986.s17.e0" text="triptolide" /></sentence><sentence text="" /></document>